-
Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients with Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Study
phs003019
-
Assessing Individual Head and Neck Squamous Cell Carcinoma Patient Response to Therapy Through Integration of Functional and Genomic Data
Study
phs003456
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
SMPaeds PanelSeq of cfDNA at relapse with UMIs
Dataset
EGAD50000000781
-
Reference epigenome DB31_N_Alpha_mRNA-Seq data generated from KEP study
Dataset
EGAD00001003485
-
Reference epigenome DB31_N_Alpha_smRNA-Seq data generated from KEP study
Dataset
EGAD00001003494
-
Reference epigenome ADMSC01_smRNA-Seq data generated from KEP study
Dataset
EGAD00001003867
-
Reference epigenome ADMSC02_smRNA-Seq data generated from KEP study
Dataset
EGAD00001003868
-
Reference epigenome ADMSC03_smRNA-Seq data generated from KEP study
Dataset
EGAD00001003869
-
Reference epigenome KNIH005 WGBS data generated from KEP study
Dataset
EGAD00001002753